Cited by 1,001Lipoproteins and Cardiovascular HealthCardiac and Coronary Surgery TechniquesCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Open access

Buchwald, Henry, Varco, Richard L., Matts, John P., Long, John M., Fitch, Laurie L., Campbell, Gilbert S., Pearce, Malcolm B., Yellin, Albert E., Edmiston, W. Allan, Smink, Robert D., Sawin, Henry S., Campos, Christian T., Hansen, Betty J., Tuna, Naip, Karnegis, James N., Sanmarco, Miguel E., Amplatz, Kurt, Castaneda-Zuniga, Wilfredo R., Hunter, David W., Bissett, Joseph K., Weber, Frederic J., Stevenson, James W., Leon, Arthur S., Chalmers, Thomas C.·1990·New England Journal of Medicine

DOI 10.1056/nejm199010043231404

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND AND METHODS: The Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized clinical trial, was designed to test whether cholesterol lowering induced by the partial ileal bypass operation would favorably affect overall mortality or mortality due to coronary heart disease. The study population consisted of 838 patients (417 in the control group and 421 in the surgery group), both men (90.7 percent) and women, with an average age of 51 years, who had survived a first myocardial infarction. The mean follow-up period was 9.7 years. RESULTS: When compared with the control group at five years, the surgery group had a total plasma cholesterol level 23.3 percent lower (4.71 +/- 0.91 vs. 6.14 +/- 0.89 mmol per liter [mean +/- SD]; P less than 0.0001), a low-density lipoprotein cholesterol level 37.7 percent lower (2.68 +/- 0.78 vs. 4.30 +/- 0.89 mmol per liter; P less than 0.0001), and a high-density lipoprotein cholesterol level 4.3 percent higher (1.08 +/- 0.26 vs. 1.04 +/- 0.25 mmol per liter; P = 0.02). Overall mortality and mortality due to coronary heart disease were reduced, but not significantly so (deaths overall [control vs. surgery], 62 vs. 49, P = 0.164; deaths due to coronary disease, 44 vs. 32, P = 0.113). The overall mortality in the surgery subgroup with an ejection fraction greater than or equal to 50 percent was 36 percent lower (control vs. surgery, 39 vs. 24; P = 0.021). The value for two end points combined--death due to coronary heart disease and confirmed nonfatal myocardial infarction--was 35 percent lower in the surgery group (125 vs. 82 events; P less than 0.001). During follow-up, 137 control-group and 52 surgery-group patients underwent coronary-artery bypass grafting (P less than 0.0001). A comparison of base-line coronary arteriograms with those obtained at 3, 5, 7, and 10 years consistently showed less disease progression in the surgery group (P less than 0.001). The most common side effect of partial ileal bypass was diarrhea; others included occasional kidney stones, gallstones, and intestinal obstruction. CONCLUSIONS: Partial ileal bypass produces sustained improvement in the blood lipid patterns of patients who have had a myocardial infarction and reduces their subsequent morbidity due to coronary heart disease. The role of this procedure in the management of hypercholesterolemia remains to be determined. These results provide strong evidence supporting the beneficial effects of lipid modification in the reduction of atherosclerosis progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199010043231404

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Practical Nonparametric Statistics
Groggel, D. J., & Conover, W. J. (2000) · Technometrics · doi:10.2307/1271101 · Cited by 11,076
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,091
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease
(1984) · JAMA · doi:10.1001/jama.1984.03340270029025 · Cited by 2,747
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160

Show all 58 references

Research works printed but not linked: 29

10.1001/jama.256.20.2823 · DOI · Paper page
Leren, 1966, Acta Med Scand Suppl, 466, 1
1968, Lancet, 2, 693
Frantz, 1975, Circulation, 52, II-4
10.1001/jama.231.4.360 · DOI
10.1001/jama.251.3.351 · DOI · Paper page
10.1001/jama.257.23.3233 · DOI
Buchwald H. Intestinal bypass for hypercholesterolemia. In: Nyhus LM, Baker RJ, eds. Mastery of surgery. Vol. 3. Boston: Little, Brown, 1984:901–7.
Buchwald H, Campos CT. Partial ileal bypass for control of hyperlipidemia and atherosclerosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: W.B. Saunders, 1990:1799–819.
Schouten, 1986, Artery, 13, 240
1959, Stat Bull Metrop Life Insur Co, 40, 1
Bruce, 1971, Ann Clin Res, 3, 323
National Heart and Lung Institute, Lipid Research Clinics Program. Manual of laboratory operations. Vol. 1. Bethesda, Md.: National Institutes of Health, 1974. (DHEW publication no. (NIH) 75–628.)
1970, Bull World Health Organ, 43, 891
Mantel, 1966, Cancer Chemother Rep, 50, 163
Matts, Controlled Clin Trials
Campos, 1987, Surgery, 102, 424
Campos, 1988, Curr Surg, 45, 380
Campos, 1988, Surg Forum, 39, 193
Addison, 1851, Guys Hosp Rep, 2, 267
Ignatovski, 1908, Izviest Imp Voyenno-med Akad S Petersb, 16, 154
Anitschkow, 1913, Centralbl Allg Pathol Pathol Anat, 24, 1
Wacker, 1913, Münchener Med Wochenschr, 60, 2097
European Coronary Surgery Study Group, 1982, Lancet, 2, 1173
Buchwald, 1965, Surgery, 58, 22
Scott, 1967, Surg Gynecol Obstet, 125, 3
Buchwald, 1963, Circulation, 28, II-649
Moore, 1969, Surgery, 65, 98
Buchwald, Ann Surg

Sorted by citations

Items 701–800 of 1,000

The state of dyslipidemia after laparoscopic sleeve gastrectomy
Hussein, A. M. (2018) · International Surgery Journal · doi:10.18203/2349-2902.isj20182394 · Cited by 3
A renaissance for cardio-metabolic surgery: better outcomes and lower costs?
Wierzbicki, A. S., Hubbard, J. G. H., & Botha, A. J. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02696.x · Cited by 3
Koronare Herzkrankheit und Herzinfarkt
Meyer, J., Bockisch, A., Darius, H., Heusch, G., Hort, W., Mohr-Kahaly, S., Rupprecht, H. J., & Voigtländer, T. (2005) · Springer eBooks · doi:10.1007/3-540-29425-2_2 · Cited by 3
Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era
Ebisawa, S., Izawa, A., Ueki, Y., Hioki, H., Minamisawa, M., Hashizume, N., Abe, N., Kashima, Y., Miura, T., Takeuchi, T., et al. (2015) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2015.07.007 · Cited by 3
Long-term Mortality After Primary Prevention for Cardiovascular Disease
Newman, T. B. (1992) · JAMA · doi:10.1001/jama.1992.03480160041018 · Cited by 3
Treating serum lipid abnormalities in high-priority patients
Blankenhorn, D. H., & Hodis, H. N. (1991) · Postgraduate Medicine · doi:10.1080/00325481.1991.11700787 · Cited by 3
Long-Term Prognosis after Recovery from Myocardial Infarction: A Community-Based Survey in Yamagata, Japan.
Kubota, I., Matsui, M., Ito, H., Saito, M., Yokoyama, K., Yasumura, S., & Tomoike, H. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.589 · Cited by 3
Aggressive medical therapy for the prevention and treatment of coronary artery disease.
Malloy, M., & Kane, J. (1997) · Advances in internal medicine · doi:10.1016/s0011-5029(98)90000-1 · Cited by 2
What does the future hold for the patient with peripheral arterial disease?
Sillesen, H. H. (2004) · European Heart Journal Supplements · doi:10.1016/j.ehjsup.2004.04.008 · Cited by 3
The Potential Role of Anti-PCSK9 Monoclonal Antibodies in the Management of Hypercholesterolemia
Lepor, N. E., Contreras, L., Desai, C., & Kereiakes, D. J. (2014) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0773 · Cited by 3
The Steps Beyond Diet and Drug Therapy for Severe Hypercholesterolemia
Gordon, B. R., & Hudgins, L. C. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50035-8 · Cited by 3
A rodent model of partial intestinal diversion: a novel metabolic operation
Alvarez, R., Sandoval, D. A., & Seeley, R. J. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.026 · Cited by 3
Dyslipidemia
Cohen, A. M., & Rader, D. J. (2001) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-001-0096-4 · Cited by 3
History and development of HMG-CoA reductase inhibitors
Bellosta, S., Paoletti, R., & Corsini, A. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8135-7_1 · Cited by 4
Lipid Modulation and Liver Function Tests: A Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
Buchwald, H., Williams, S. E. I., Matts, J. P., & Boen, J. R. (2002) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670200900203 · Cited by 3
Self-citation
The Clinical Profile of Atherosclerosis
Callow, A. D. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2437-3_8 · Cited by 3
Clinical and angiographic variables affecting the progression of coronary artery disease as determined by quantitative angiography
Joseph, A., Talley, J. D., Shih, A., Crum, T., Vogel, R. L., & Kupersmith, J. (1994) · International journal of cardiac imaging · doi:10.1007/bf01137903 · Cited by 3
An Organizational Model to Translate Nutritional Recommendations into Routine Clinical Practice in Secondary Prevention of Coronary Artery Disease
Aquilani, R., Boni, S., Verdirosi, S., Pastoris, O., Assandri, J., Rossi, A., Paganini, V., Riccardi, R., Cajelli, A., Pernice, M., et al. (2002) · Preventive Medicine · doi:10.1006/pmed.2001.0958 · Cited by 3
Dietary Treatment of Hyperlipidemia
Gotto, A. M., & Ballantyne, C. M. (1994) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679400100401 · Cited by 3
Femoral and coronary angiographic trials.
Cashin-Hemphill, L. (1993) · American Journal of Cardiology · doi:10.1016/0002-9149(93)90141-x · Cited by 4
Risk factors for coronary disease and stroke in men and women
Isles, C., Hole, D. J., Lever, A. F., & Hawthorne, V. M. (1996) · QJM · doi:10.1093/qjmed/89.5.343 · Cited by 3
Best practice — ongoing polemics
Paoletti, R., & Bellosta, S. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00100-8 · Cited by 3
What do angiographic changes after cholesterol lowering mean?
Ravnskov, U. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90783-8 · Cited by 3
Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982–1992
Gordon, B. R., & Saal, S. D. (1993) · Transfusion Science · doi:10.1016/0955-3886(93)90006-g · Cited by 3
Lipid Lowering Therapy
Smith, D. A. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5007-5_4 · Cited by 3
Prevention of cardiovascular disease
Barbir, M., Lazem, F., & Ilsley, C. D. J. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-5406-2_35 · Cited by 3
Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia
Visseren, F. L. J. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0078-4 · Cited by 3
Enhanced Hype
Harrison, D. G., Brown, W. V., & Raggi, P. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.017 · Cited by 3
The Role of Aggressive Lipid Lowering Therapy for Coronary Artery Disease
Daida, H., Fukushima, Y., & Ohmura, H. (2019) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.2019.65.jmj18-ln05 · Cited by 2
Assessment of Lipoproteins
Wieland, H. (1997) · Springer eBooks · doi:10.1007/978-3-642-60512-3_10 · Cited by 2
Bile Acids and Their Receptors
Claudel, T., & Trauner, M. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_21 · Cited by 2
Chapter 11 A cerebrovascular perspective of atherosclerosis
Nichols, F. T., Shaltoni, H. M., & Yatsu, F. M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)01911-8 · Cited by 2
Assessing cardiac risks in police officers
Brown, J. D., & Trottier, A. (1995) · Journal of Clinical Forensic Medicine · doi:10.1016/1353-1131(95)90004-7 · Cited by 2
Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology
Ray, K. K., & Cannon, C. P. (2005) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200502000-00006 · Cited by 2
Role of the surgeon in managing hypercholesterolemia
Buchwald, H. (1999) · Surgery · doi:10.1016/s0039-6060(99)70195-9 · Cited by 2
Self-citation
Hyperlipidemia in Peripheral Arterial Disease
Babu, A. R., Kannan, C., & Mazzone, T. (2005) · Humana Press eBooks · doi:10.1385/1-59259-881-1:061 · Cited by 2
De la chirurgie bariatrique à la chirurgie métabolique : une histoire en devenir Partie 1. L’histoire de la chirurgie bariatrique
Schlienger, J.-L. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30256-x · Cited by 2
Prevention of Peripheral Artery Atherosclerosis
Kröger, K. (2002) · Springer eBooks · doi:10.1007/978-3-642-56225-9_84 · Cited by 2
Statins and Inhibition of Atherosclerosis: Human Studies
Sinha, A. K., Singh, B. M., & Mehta, J. L. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7216-0380-3.50008-9 · Cited by 2
Lipoproteins and Apoproteins
Citkowitz, E., & Herbert, P. N. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5007-5_3 · Cited by 2
Assessing and Reporting Adverse Effects
Friedman, L. M., Furberg, C. D., & DeMets, D. L. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2915-3_11 · Cited by 2
Epidemiology of hyperlipidemia and the efficacy of pravastatin therapy
The Pravastatin Collaborative Study Group (1993) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80629-0 · Cited by 2
Significance of graft occlusion and coronary atherosclerosis 5 years after coronary artery bypass grafting. A quantitative angiographic study with serial exercise testing
Korpilahti, K., Engblom, E., Hämäläinen, H., Syvänne, M., Hietanen, E. K., Arstila, M., Puukka, P. J., & Rönnemaa, T. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00453.x · Cited by 2
Sucralfate on Serum Lipids and Lipoproteins in Normal Volunteers
Schwenk, M. H., Berk, S. I., Morgan, D. V., Maesaka, J. K., & Lehrer, M. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb02041.x · Cited by 2
Statins
McKenney, J. M., & Roth, E. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00021-9 · Cited by 2
Regression of atherosclerosis--an ounce of prevention.
Bg, B. (1993) · PubMed Central · Cited by 2
Progression and regression of coronary atherosclerosis: data from a controlled clinical trial with nicardipine
Waters, D. D., & Lespérance, J. (1993) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1854-5_16 · Cited by 2
Studies on antioxidant and lipid lowering effects on human microcirculation
Lu, Q. (2002) · Figshare · Cited by 2
Regression of atherosclerosis.
Leiter, L. A. (1991) · Europe PMC (PubMed Central) · Cited by 2
On lowering lipids in the post‐infarction patient
Lewis, B. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00381.x · Cited by 2
Lipid management in patients with vascular disease
Kohlman-Trigoboff, D. (2005) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2005.03.002 · Cited by 2
Can any agreement be reached on cholesterol lowering?
Durrington, P. (1994) · British heart journal · doi:10.1136/hrt.71.2.125 · Cited by 2
Haemostatic system and arterial disease: future perspectives
Meade, T. W. (1997) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(97)80046-x · Cited by 2
Cholesterol confusion in primary prevention of coronary artery disease
Opie, L. H. (1993) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00878930 · Cited by 2
Is there an association among low untreated serum lipid levels, anger, and hazardous driving?
Davidson, K., Reddy, S., McGrath, P. J., & Zitner, D. (1996) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0304_3 · Cited by 2
Developing a clinical strategy for cholesterol management in an era of unanswered questions
Ansell, B. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01874-4 · Cited by 2
What's in the CARDS?
Plummer, C. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01903.x · Cited by 2
Lowering blood lipids to treat atherosclerosis: Vascular tone, plaques, events, and mortality
Rubba, P., Pauciullo, P., & Mancini, M. (1993) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00878928 · Cited by 2
Noninvasive and invasive testing after myocardial infarction
O’Rourke, R. A. (1991) · Current Problems in Cardiology · doi:10.1016/0146-2806(91)90017-5 · Cited by 2
Evolución de la dislipemia en pacientes intervenidos mediante derivación biliopancreática de Larrad
Jiménez, Á. L., Sánchez‐Cabezudo, C., Borrajo, P. P. D. Q., García, I. R., & Esteban, B. M. (2003) · Cirugía Española · doi:10.1016/s0009-739x(03)72111-3 · Cited by 2
When do we treat hypercholesterolemia?
Brown, W. V. (1992) · Clinical Cardiology · doi:10.1002/clc.4960151005 · Cited by 2
Behandlung von Fettstoffwechselstörungen: Wann? Warum?
Steinmetz, A. (1992) · Springer eBooks · doi:10.1007/978-3-642-77813-1_1 · Cited by 2
The impact of the calcium antagonist nifedipine on the angiographic progression of coronary artery disease: Results of the INTACT (international nifedipine trial on antiatherosclerotic therapy)
The INTACT study group, Lichtlen, P. R., Rafflenbeul, W., Jost, S., Nikutta, P., Hugenholtz, P. G., Deckers, J. W., & Wiese, B. (1993) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1854-5_15 · Cited by 2
Prevention of Heart Disease: Is LDL Reduction the Outcome of Choice? Absolutely Yes
Stein, E. A. (1998) · Value in Health · doi:10.1046/j.1524-4733.1998.120115.x · Cited by 2
The diagnosis and management of familial hypercholesterolaemia.
Marais, A., & Jc, F. (2005) · PubMed · Cited by 2
All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT
Caterina, R. D., Salvatore, T., & Marchioli, R. (2016) · Data in Brief · doi:10.1016/j.dib.2016.04.059 · Cited by 2
Threshold level or not for low-density lipoprotein cholesterol.
Barter, P. J., & Sacks, F. M. (2001) · PubMed · Cited by 2
Prevention Of Cardiovascular Events By Hypolipidemic Therapy Evidence-Based Medicine Criteria
Heller, F. (1999) · Acta Clinica Belgica · doi:10.1080/17843286.1999.11754249 · Cited by 2
Interventions to Lower Low-Density Lipoprotein Cholesterol and Cardiovascular Risk
Navarese, E. P., Kołodziejczak, M. M., & Servi, S. D. (2017) · JAMA · doi:10.1001/jama.2016.19058 · Cited by 2
The 1984 Coronary Primary Prevention Trial
Steinberg, D. H. (2007) · Elsevier eBooks · doi:10.1016/b978-012373979-7/50039-x · Cited by 2
Arteriosklerose
Greten, H., Rieger, H., Sinzinger, H. F., Standl, E., & Windler, E. E. T. (1998) · Springer eBooks · doi:10.1007/978-3-662-08104-4_4 · Cited by 2
LOW DENSITY LIPOPROTEIN CHOLESTEROL LOWERING: ARE THE TREATMENT GUIDELINES STILL APPROPRIATE?
Deslypere, J.-P. (2000) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2000.tb11909.x · Cited by 2
Gene therapy for the vulnerable atherosclerotic plaque
Feldman, L. J., & Isner, J. M. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-1577-0_24 · Cited by 2
Mechanisms of weight recurrence after bariatric surgery
Yadav, R. K., Zhang, Y., Lv, Y., Liu, S., Yang, J., Wang, Y., & Gang, X. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01115-2 · Cited by 2
Pathophysiology of Vascular Disease
Zarins, C. K., Xu, C., & Glagov, S. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1387-6_2 · Cited by 1
POSCH trial 25-year follow-up results: latest news from an old kid on the block
Cintra, R. M. R., & Sposito, A. C. (2010) · Clinical Lipidology · doi:10.2217/clp.10.58 · Cited by 1
Surgical Intervention For The Treatment Of Morbid Obesity And The Dyslipidemias
Buchwald, H. (2007) · Future Lipidology · doi:10.2217/17460875.2.5.513 · Cited by 1
Self-citation
Cardiac rehabilitation for older people
Todd, I. C., Donald, S. M., & Pentland, B. T. (1995) · Reviews in Clinical Gerontology · doi:10.1017/s0959259800004366 · Cited by 1
Rosuvastatin: An Effective Lipid Lowering Drug against Hypercholesterolemia
(2006) · The Internet Journal of Cardiovascular Research · doi:10.5580/22bb · Cited by 1
Coronary Heart Disease
Stewart, B. F. (1995) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(18)30477-7 · Cited by 1
Geschichte der Adipositaschirurgie in Deutschland
Weiner, R. A. (2018) · Springer eBooks · doi:10.1007/978-3-662-57364-8_1 · Cited by 1
Why not to interfere with LDL-cholesterol freefall and why not to talk badly about statins
Pitha, J. V. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.168 · Cited by 1
Reductase inhibitor therapy of hypercholesterolemia.
Kreisberg, R. A. (1991) · PubMed Central · Cited by 1
New Perspectives in COPD Management
Yawn (2021) · The Journal of Family Practice · doi:10.12788/jfp.0220 · Cited by 1
DYSLIPIDEMIAS
Murphy, M. S., & O’Brien, T. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50027-5 · Cited by 2
Metabolic surgery: Quo Vadis?
Ramos-Levi, A. M., & Rubio, M. Á. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.01.012 · Cited by 1
Modern management of acute myocardial infarction
Brilakis, E. S., Reeder, G. S., & Gersh, B. J. (2003) · Current Problems in Cardiology · doi:10.1016/s0146-2806(03)70001-2 · Cited by 1
Partial Ileal Bypass — Results of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
The Posch Group, Buchwald, H., & Campos, C. T. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_37 · Cited by 1
Self-citation
Long-Term Impact of Weight Loss on Obesity and Obesity-Associated Comorbidities
Hwang, J. J., Blackburn, G. L., & Mantzoros, C. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-453-1_18 · Cited by 1
Pathophysiological basis for lipid intervention trials
Buchwald, H., & Campos, C. T. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0143-8_2 · Cited by 1
Self-citation
Efeito da Lecitina de Soja sobre os Lipídeos e Proteína C reativa e na prevenção da Hipertrofia Ventricular Esquerda de Camundongos Hiperlipidêmicos
Calderon, H., Carvalho, A. J. P., Oliveira, I. C. R., Soares, E. A., Loyola, Y. C. S., dos Santos, L., Messora, L. B., Pereira, J. E. G., Incerpi, E. K., Lobão, P. H. O. A., et al. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
LDL-cholesterol lowering and atherosclerosis - clinical benefit and possible mechanisms: an update
Kroon, A. A., & Stalenhoef, A. F. H. (1997) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(97)00031-4 · Cited by 1
METABOLIC SURGERY: A NEW APPROACH IN THE TREATMENT OF METABOLIC DISEASE OF THE 21ST CENTURY
Wei, T. K., Hang, D. W. C., Kim, A. E. H., & Pasupathy, S. (2011) · The Singapore Family Physician · Cited by 1
Relationship between cholesterol synthesis/absorption marker and vascular function in healthy subjects
Ishibashi, Y., Karino, K., Yano, S., Kijima, T., Takahashi, N., Yamagata, S., KUROKOUCHI, K., Nagami, H., Honda, S., & Nosou, Y. (2018) · Vascular Failure · doi:10.30548/vascfail.2.1_20 · Cited by 1
Patologías asociadas a la obesidad
Buchwald, H. (2009) · Elsevier eBooks · doi:10.1016/b978-84-8086-428-2.50005-8 · Cited by 1
Self-citation
Decision Points in the Management of Patients with Diabetic Kidney Disease
Weir (2021) · The Journal of Family Practice · doi:10.12788/jfp.0217 · Cited by 1
Utilizing CGM Ambulatory Glucose Profiles to Optimize Diabetes Management
Miller (2021) · The Journal of Family Practice · doi:10.12788/jfp.0226 · Cited by 1
INHIBITION OF THE RATE-LIMITING ENZYME IN CHOLESTEROL BIOSYNTHESIS LEADS TO UP-REGULATION OF THE LDL RECEPTOR
(2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1991.tb03009.x · Cited by 1
Preventive medicine in primary care: management of hyperlipidaemia.
Lewis, B. (1992) · Europe PMC (PubMed Central) · Cited by 1
Usefulness of Intravascular Ultrasound for Detecting Atherosclerosis Progression Or Regression
Hong, M. K., Leon, M. B., & Mintz, G. S. (1997) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-6287-0_10 · Cited by 1

Authors: Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., Sawin, H. S., Campos, C. T., Hansen, B. J., Tuna, N., Karnegis, J. N., Sanmarco, M. E., Amplatz, K., Castaneda-Zuniga, W. R., Hunter, D. W., Bissett, J. K., Weber, F. J., Stevenson, J. W., Leon, A. S., & Chalmers, T. C.
Affiliations: University of Minnesota (US)
University of Southern California (US)
ORCID: Long, John M.
Hunter, David W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1990-10-04
Volume: 323
Issue: 14
Pages: 946-955
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199010043231404
OpenAlex: W2331959986
Cited by: 1,001
References: 58
Citations by year: 2026: 3 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 20 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 22 · 2015: 15 · 2014: 17 · 2013: 12 · 2012: 17
FWCI: 84.71
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: partial ileal bypass, hypercholesterolemia, coronary artery disease, mortality, myocardial infarction, cholesterol lowering, LDL cholesterol, HDL cholesterol, first myocardial infarction, coronary artery bypass grafting, ejection fraction, long-term outcomes, nonfatal myocardial infarction
MeSH terms: Adult, Coronary Disease, Electrocardiography, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hyperlipidemias, Jejunoileal Bypass, Lipids, Male, Middle Aged, Ultrasonography, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Coronary Angiography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks